Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Nitinol Thrombectomy Stent Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Nitinol Thrombectomy Stent Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 155 Pages
Report ld: 6261327
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Nitinol Thrombectomy Stent Market Size(US$)
CAGR 2026-2032
9.5%
Market Size,2032
USD 411
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 239 million
Market Forecast in 2032(Value)
US$ 411 million
CAGR
9.5%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Nitinol Thrombectomy Stent market is projected to grow from US$ 218 million in 2025 to US$ 411 million by 2032, at a CAGR of 9.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The Nitinol Thrombectomy Stent utilizes the unique superelasticity and shape memory properties of Nitinol to integrate with the thrombus for effective mechanical removal while preserving vessel integrity. Engineered with a highly visible, radiopaque structure and a controlled radial expansion force, this device allows for precise deployment and retrieval within the intricate neurovascular or peripheral vasculature. Its open-cell design facilitates maximum metal-to-thrombus contact to securely engage the occlusion, minimizing the risk of distal embolization and ensuring complete restoration of blood flow. In 2025, global Nitinol Thrombectomy Stent production reached approximately 218 k units with an average global market price of around US$1000 per unit.
As indications expand from acute ischemic stroke to areas such as pulmonary embolism and deep vein thrombosis, the Nitinol Thrombectomy Stent industry is witnessing a significant expansion in market capacity, providing robust momentum for corporate revenue growth. Technological iteration is currently focusing on precision manufacturing and material refinement, aiming to achieve product differentiation by enhancing operational convenience, strengthening radial support, and optimizing delivery system flexibility, thereby maintaining high pricing power and profit margins amidst intense market competition. Simultaneously, the development of specialized stents tailored to different vascular anatomies aligns with the trend of precision medicine, helping enterprises capture high-value market segments. Furthermore, in the face of industry reshaping driven by global healthcare cost containment and normalized centralized procurement, companies with core technological barriers, extensive clinical data, and scalable production capabilities are optimizing cost structures through economies of scale, driving market share toward top-tier players. In the future, the industry will also gradually explore intelligent integration with robotic-assisted surgical systems to adapt to the evolving operating room ecosystem, further solidifying long-term profitability.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Nitinol Thrombectomy Stent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Medtronic
- Acandis
- TERUMO
- Stryker
- Johnson & Johnson
- Penumbra
- Phenox
- Rapid Medical
- Furukawa
- Shandong Weigao Group Medical Polymer Company
- Shanghai Skynor Medical
- HeMo Bioengineering
- Suzhou Zenith Vascular Scitech
- Shanghai HeartCare Medical Technology Corporations
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Diameter 3MM
- Diameter 4MM
- Diameter 6MM
- Other
Segment by Application
- Hospital
- Clinic
- Other
Segment by Category
- Self-expanding Nitinol Stent
- Balloon-expandable Stent
Segment by Division
- Superelastic Nitinol Stent
- Shape Memory Nitinol Stent
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Nitinol Thrombectomy Stent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Nitinol Thrombectomy Stent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Nitinol Thrombectomy Stent Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Diameter 3MM
1.2.3 Diameter 4MM
1.2.4 Diameter 6MM
1.2.5 Other
1.3 Market Segmentation by Deployment Mechanism
1.3.1 Global Nitinol Thrombectomy Stent Market Size by Deployment Mechanism, 2021 vs 2025 vs 2032
1.3.2 Self-expanding Nitinol Stent
1.3.3 Balloon-expandable Stent
1.4 Market Segmentation by Material Condition
1.4.1 Global Nitinol Thrombectomy Stent Market Size by Material Condition, 2021 vs 2025 vs 2032
1.4.2 Superelastic Nitinol Stent
1.4.3 Shape Memory Nitinol Stent
1.4.4 Others
1.5 Market Segmentation by Application
1.5.1 Global Nitinol Thrombectomy Stent Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Nitinol Thrombectomy Stent Revenue Estimates and Forecasts (2021-2032)
2.2 Global Nitinol Thrombectomy Stent Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Nitinol Thrombectomy Stent Sales Estimates and Forecasts (2021-2032)
2.4 Global Nitinol Thrombectomy Stent Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Nitinol Thrombectomy Stent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Nitinol Thrombectomy Stent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Diameter 3MM: Market Share by Key Manufacturers
3.5.2 Diameter 4MM: Market Share by Key Manufacturers
3.5.3 Diameter 6MM: Market Share by Key Manufacturers
3.5.4 Other: Market Share by Key Manufacturers
3.6 Global Nitinol Thrombectomy Stent Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Nitinol Thrombectomy Stent Sales Performance by Type
4.1.1 Global Nitinol Thrombectomy Stent Sales Volume by Type (2021-2032)
4.1.2 Global Nitinol Thrombectomy Stent Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Nitinol Thrombectomy Stent Sales Performance by Deployment Mechanism
4.2.1 Global Nitinol Thrombectomy Stent Sales Volume by Deployment Mechanism (2021-2032)
4.2.2 Global Nitinol Thrombectomy Stent Revenue by Deployment Mechanism (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Deployment Mechanism (2021-2032)
4.3 Global Nitinol Thrombectomy Stent Sales Performance by Material Condition
4.3.1 Global Nitinol Thrombectomy Stent Sales Volume by Material Condition (2021-2032)
4.3.2 Global Nitinol Thrombectomy Stent Revenue by Material Condition (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Material Condition (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Nitinol Thrombectomy Stent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Nitinol Thrombectomy Stent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Nitinol Thrombectomy Stent Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Nitinol Thrombectomy Stent Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Nitinol Thrombectomy Stent Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Nitinol Thrombectomy Stent Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Nitinol Thrombectomy Stent Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Nitinol Thrombectomy Stent Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Nitinol Thrombectomy Stent Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Nitinol Thrombectomy Stent Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Nitinol Thrombectomy Stent Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Nitinol Thrombectomy Stent Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.1.4 Medtronic Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Medtronic Nitinol Thrombectomy Stent Sales by Product in 2025
11.1.6 Medtronic Nitinol Thrombectomy Stent Sales by Application in 2025
11.1.7 Medtronic Nitinol Thrombectomy Stent Sales by Geographic Area in 2025
11.1.8 Medtronic Nitinol Thrombectomy Stent SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Acandis
11.2.1 Acandis Corporation Information
11.2.2 Acandis Business Overview
11.2.3 Acandis Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.2.4 Acandis Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Acandis Nitinol Thrombectomy Stent Sales by Product in 2025
11.2.6 Acandis Nitinol Thrombectomy Stent Sales by Application in 2025
11.2.7 Acandis Nitinol Thrombectomy Stent Sales by Geographic Area in 2025
11.2.8 Acandis Nitinol Thrombectomy Stent SWOT Analysis
11.2.9 Acandis Recent Developments
11.3 TERUMO
11.3.1 TERUMO Corporation Information
11.3.2 TERUMO Business Overview
11.3.3 TERUMO Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.3.4 TERUMO Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 TERUMO Nitinol Thrombectomy Stent Sales by Product in 2025
11.3.6 TERUMO Nitinol Thrombectomy Stent Sales by Application in 2025
11.3.7 TERUMO Nitinol Thrombectomy Stent Sales by Geographic Area in 2025
11.3.8 TERUMO Nitinol Thrombectomy Stent SWOT Analysis
11.3.9 TERUMO Recent Developments
11.4 Stryker
11.4.1 Stryker Corporation Information
11.4.2 Stryker Business Overview
11.4.3 Stryker Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.4.4 Stryker Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Stryker Nitinol Thrombectomy Stent Sales by Product in 2025
11.4.6 Stryker Nitinol Thrombectomy Stent Sales by Application in 2025
11.4.7 Stryker Nitinol Thrombectomy Stent Sales by Geographic Area in 2025
11.4.8 Stryker Nitinol Thrombectomy Stent SWOT Analysis
11.4.9 Stryker Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.5.4 Johnson & Johnson Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Johnson & Johnson Nitinol Thrombectomy Stent Sales by Product in 2025
11.5.6 Johnson & Johnson Nitinol Thrombectomy Stent Sales by Application in 2025
11.5.7 Johnson & Johnson Nitinol Thrombectomy Stent Sales by Geographic Area in 2025
11.5.8 Johnson & Johnson Nitinol Thrombectomy Stent SWOT Analysis
11.5.9 Johnson & Johnson Recent Developments
11.6 Penumbra
11.6.1 Penumbra Corporation Information
11.6.2 Penumbra Business Overview
11.6.3 Penumbra Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.6.4 Penumbra Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Penumbra Recent Developments
11.7 Phenox
11.7.1 Phenox Corporation Information
11.7.2 Phenox Business Overview
11.7.3 Phenox Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.7.4 Phenox Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Phenox Recent Developments
11.8 Rapid Medical
11.8.1 Rapid Medical Corporation Information
11.8.2 Rapid Medical Business Overview
11.8.3 Rapid Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.8.4 Rapid Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Rapid Medical Recent Developments
11.9 Furukawa
11.9.1 Furukawa Corporation Information
11.9.2 Furukawa Business Overview
11.9.3 Furukawa Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.9.4 Furukawa Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Furukawa Recent Developments
11.10 Shandong Weigao Group Medical Polymer Company
11.10.1 Shandong Weigao Group Medical Polymer Company Corporation Information
11.10.2 Shandong Weigao Group Medical Polymer Company Business Overview
11.10.3 Shandong Weigao Group Medical Polymer Company Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.10.4 Shandong Weigao Group Medical Polymer Company Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Shandong Weigao Group Medical Polymer Company Recent Developments
11.11 Shanghai Skynor Medical
11.11.1 Shanghai Skynor Medical Corporation Information
11.11.2 Shanghai Skynor Medical Business Overview
11.11.3 Shanghai Skynor Medical Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.11.4 Shanghai Skynor Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Shanghai Skynor Medical Recent Developments
11.12 HeMo Bioengineering
11.12.1 HeMo Bioengineering Corporation Information
11.12.2 HeMo Bioengineering Business Overview
11.12.3 HeMo Bioengineering Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.12.4 HeMo Bioengineering Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 HeMo Bioengineering Recent Developments
11.13 Suzhou Zenith Vascular Scitech
11.13.1 Suzhou Zenith Vascular Scitech Corporation Information
11.13.2 Suzhou Zenith Vascular Scitech Business Overview
11.13.3 Suzhou Zenith Vascular Scitech Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.13.4 Suzhou Zenith Vascular Scitech Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Suzhou Zenith Vascular Scitech Recent Developments
11.14 Shanghai HeartCare Medical Technology Corporations
11.14.1 Shanghai HeartCare Medical Technology Corporations Corporation Information
11.14.2 Shanghai HeartCare Medical Technology Corporations Business Overview
11.14.3 Shanghai HeartCare Medical Technology Corporations Nitinol Thrombectomy Stent Product Models, Descriptions and Specifications
11.14.4 Shanghai HeartCare Medical Technology Corporations Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Shanghai HeartCare Medical Technology Corporations Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Nitinol Thrombectomy Stent Industry Chain
12.2 Nitinol Thrombectomy Stent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Nitinol Thrombectomy Stent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Nitinol Thrombectomy Stent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Nitinol Thrombectomy Stent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Nitinol Thrombectomy Stent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Deployment Mechanism, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Material Condition, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Nitinol Thrombectomy Stent Revenue by Region (US$ Million), 2021-2026
Table 7. Global Nitinol Thrombectomy Stent Revenue by Region (US$ Million), 2027-2032
Table 8. Global Nitinol Thrombectomy Stent Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Nitinol Thrombectomy Stent Sales by Region (K Units), 2021-2026
Table 10. Global Nitinol Thrombectomy Stent Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Nitinol Thrombectomy Stent Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Nitinol Thrombectomy Stent Sales Share by Manufacturers (2021-2026)
Table 14. Global Nitinol Thrombectomy Stent Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Nitinol Thrombectomy Stent Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Nitinol Thrombectomy Stent Revenue, 2025
Table 18. Global Nitinol Thrombectomy Stent Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Nitinol Thrombectomy Stent Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Nitinol Thrombectomy Stent Manufacturing Base and Headquarters
Table 21. Global Nitinol Thrombectomy Stent Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Nitinol Thrombectomy Stent Sales Volume by Type (K Units), 2021-2026
Table 25. Global Nitinol Thrombectomy Stent Sales Volume by Type (K Units), 2027-2032
Table 26. Global Nitinol Thrombectomy Stent Revenue by Type (US$ Million), 2021-2026
Table 27. Global Nitinol Thrombectomy Stent Revenue by Type (US$ Million), 2027-2032
Table 28. Global Nitinol Thrombectomy Stent Sales Volume by Deployment Mechanism (K Units), 2021-2026
Table 29. Global Nitinol Thrombectomy Stent Sales Volume by Deployment Mechanism (K Units), 2027-2032
Table 30. Global Nitinol Thrombectomy Stent Revenue by Deployment Mechanism (US$ Million), 2021-2026
Table 31. Global Nitinol Thrombectomy Stent Revenue by Deployment Mechanism (US$ Million), 2027-2032
Table 32. Global Nitinol Thrombectomy Stent Sales Volume by Material Condition (K Units), 2021-2026
Table 33. Global Nitinol Thrombectomy Stent Sales Volume by Material Condition (K Units), 2027-2032
Table 34. Global Nitinol Thrombectomy Stent Revenue by Material Condition (US$ Million), 2021-2026
Table 35. Global Nitinol Thrombectomy Stent Revenue by Material Condition (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Nitinol Thrombectomy Stent Sales by Application (K Units), 2021-2026
Table 38. Global Nitinol Thrombectomy Stent Sales by Application (K Units), 2027-2032
Table 39. Nitinol Thrombectomy Stent High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Nitinol Thrombectomy Stent Revenue by Application (US$ Million), 2021-2026
Table 41. Global Nitinol Thrombectomy Stent Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Nitinol Thrombectomy Stent Growth Accelerators and Market Barriers
Table 45. North America Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Nitinol Thrombectomy Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Nitinol Thrombectomy Stent Growth Accelerators and Market Barriers
Table 48. Europe Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Nitinol Thrombectomy Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Nitinol Thrombectomy Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Nitinol Thrombectomy Stent Growth Accelerators and Market Barriers
Table 53. Southeast Asia Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Nitinol Thrombectomy Stent Investment Opportunities and Key Challenges
Table 55. Central and South America Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Nitinol Thrombectomy Stent Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Nitinol Thrombectomy Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Medtronic Corporation Information
Table 59. Medtronic Description and Major Businesses
Table 60. Medtronic Product Models, Descriptions and Specifications
Table 61. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Medtronic Sales Value Proportion by Product in 2025
Table 63. Medtronic Sales Value Proportion by Application in 2025
Table 64. Medtronic Sales Value Proportion by Geographic Area in 2025
Table 65. Medtronic Nitinol Thrombectomy Stent SWOT Analysis
Table 66. Medtronic Recent Developments
Table 67. Acandis Corporation Information
Table 68. Acandis Description and Major Businesses
Table 69. Acandis Product Models, Descriptions and Specifications
Table 70. Acandis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Acandis Sales Value Proportion by Product in 2025
Table 72. Acandis Sales Value Proportion by Application in 2025
Table 73. Acandis Sales Value Proportion by Geographic Area in 2025
Table 74. Acandis Nitinol Thrombectomy Stent SWOT Analysis
Table 75. Acandis Recent Developments
Table 76. TERUMO Corporation Information
Table 77. TERUMO Description and Major Businesses
Table 78. TERUMO Product Models, Descriptions and Specifications
Table 79. TERUMO Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. TERUMO Sales Value Proportion by Product in 2025
Table 81. TERUMO Sales Value Proportion by Application in 2025
Table 82. TERUMO Sales Value Proportion by Geographic Area in 2025
Table 83. TERUMO Nitinol Thrombectomy Stent SWOT Analysis
Table 84. TERUMO Recent Developments
Table 85. Stryker Corporation Information
Table 86. Stryker Description and Major Businesses
Table 87. Stryker Product Models, Descriptions and Specifications
Table 88. Stryker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Stryker Sales Value Proportion by Product in 2025
Table 90. Stryker Sales Value Proportion by Application in 2025
Table 91. Stryker Sales Value Proportion by Geographic Area in 2025
Table 92. Stryker Nitinol Thrombectomy Stent SWOT Analysis
Table 93. Stryker Recent Developments
Table 94. Johnson & Johnson Corporation Information
Table 95. Johnson & Johnson Description and Major Businesses
Table 96. Johnson & Johnson Product Models, Descriptions and Specifications
Table 97. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Johnson & Johnson Sales Value Proportion by Product in 2025
Table 99. Johnson & Johnson Sales Value Proportion by Application in 2025
Table 100. Johnson & Johnson Sales Value Proportion by Geographic Area in 2025
Table 101. Johnson & Johnson Nitinol Thrombectomy Stent SWOT Analysis
Table 102. Johnson & Johnson Recent Developments
Table 103. Penumbra Corporation Information
Table 104. Penumbra Description and Major Businesses
Table 105. Penumbra Product Models, Descriptions and Specifications
Table 106. Penumbra Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Penumbra Recent Developments
Table 108. Phenox Corporation Information
Table 109. Phenox Description and Major Businesses
Table 110. Phenox Product Models, Descriptions and Specifications
Table 111. Phenox Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Phenox Recent Developments
Table 113. Rapid Medical Corporation Information
Table 114. Rapid Medical Description and Major Businesses
Table 115. Rapid Medical Product Models, Descriptions and Specifications
Table 116. Rapid Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Rapid Medical Recent Developments
Table 118. Furukawa Corporation Information
Table 119. Furukawa Description and Major Businesses
Table 120. Furukawa Product Models, Descriptions and Specifications
Table 121. Furukawa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Furukawa Recent Developments
Table 123. Shandong Weigao Group Medical Polymer Company Corporation Information
Table 124. Shandong Weigao Group Medical Polymer Company Description and Major Businesses
Table 125. Shandong Weigao Group Medical Polymer Company Product Models, Descriptions and Specifications
Table 126. Shandong Weigao Group Medical Polymer Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Shandong Weigao Group Medical Polymer Company Recent Developments
Table 128. Shanghai Skynor Medical Corporation Information
Table 129. Shanghai Skynor Medical Description and Major Businesses
Table 130. Shanghai Skynor Medical Product Models, Descriptions and Specifications
Table 131. Shanghai Skynor Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Shanghai Skynor Medical Recent Developments
Table 133. HeMo Bioengineering Corporation Information
Table 134. HeMo Bioengineering Description and Major Businesses
Table 135. HeMo Bioengineering Product Models, Descriptions and Specifications
Table 136. HeMo Bioengineering Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. HeMo Bioengineering Recent Developments
Table 138. Suzhou Zenith Vascular Scitech Corporation Information
Table 139. Suzhou Zenith Vascular Scitech Description and Major Businesses
Table 140. Suzhou Zenith Vascular Scitech Product Models, Descriptions and Specifications
Table 141. Suzhou Zenith Vascular Scitech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Suzhou Zenith Vascular Scitech Recent Developments
Table 143. Shanghai HeartCare Medical Technology Corporations Corporation Information
Table 144. Shanghai HeartCare Medical Technology Corporations Description and Major Businesses
Table 145. Shanghai HeartCare Medical Technology Corporations Product Models, Descriptions and Specifications
Table 146. Shanghai HeartCare Medical Technology Corporations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Shanghai HeartCare Medical Technology Corporations Recent Developments
Table 148. Key Raw Materials Distribution
Table 149. Raw Materials Key Suppliers
Table 150. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 151. Milestones in Production Technology Evolution
Table 152. Distributors List
Table 153. Market Trends and Market Evolution
Table 154. Market Drivers and Opportunities
Table 155. Market Challenges, Risks, and Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Nitinol Thrombectomy Stent Product Picture
Figure 2. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Diameter 3MM Product Picture
Figure 4. Diameter 4MM Product Picture
Figure 5. Diameter 6MM Product Picture
Figure 6. Other Product Picture
Figure 7. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Deployment Mechanism, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Self-expanding Nitinol Stent Product Picture
Figure 9. Balloon-expandable Stent Product Picture
Figure 10. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Material Condition, 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Superelastic Nitinol Stent Product Picture
Figure 12. Shape Memory Nitinol Stent Product Picture
Figure 13. Others Product Picture
Figure 14. Global Nitinol Thrombectomy Stent Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Hospital
Figure 16. Clinic
Figure 17. Other
Figure 18. Nitinol Thrombectomy Stent Report Years Considered
Figure 19. Global Nitinol Thrombectomy Stent Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 21. Global Nitinol Thrombectomy Stent Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 22. Global Nitinol Thrombectomy Stent Revenue-Based Market Share by Region (2021-2032)
Figure 23. Global Nitinol Thrombectomy Stent Sales (K Units), 2021-2032
Figure 24. Global Nitinol Thrombectomy Stent Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 25. Global Nitinol Thrombectomy Stent Sales Market Share by Region (2021-2032)
Figure 26. Top 5 and Top 10 Manufacturers Nitinol Thrombectomy Stent Sales Volume Market Share in 2025
Figure 27. Global Nitinol Thrombectomy Stent Revenue-Based Market Share Ranking (2025)
Figure 28. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 29. Diameter 3MM Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Diameter 4MM Revenue-Based Market Share by Manufacturer in 2025
Figure 31. Diameter 6MM Revenue-Based Market Share by Manufacturer in 2025
Figure 32. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Global Nitinol Thrombectomy Stent Sales Volume-Based Market Share by Type (2021-2032)
Figure 34. Global Nitinol Thrombectomy Stent Revenue-Based Market Share by Type (2021-2032)
Figure 35. Global Nitinol Thrombectomy Stent ASP by Type (US$/Unit), 2021-2032
Figure 36. Global Nitinol Thrombectomy Stent Sales Volume-Based Market Share by Deployment Mechanism (2021-2032)
Figure 37. Global Nitinol Thrombectomy Stent Revenue-Based Market Share by Deployment Mechanism (2021-2032)
Figure 38. Global Nitinol Thrombectomy Stent ASP by Deployment Mechanism (US$/Unit), 2021-2032
Figure 39. Global Nitinol Thrombectomy Stent Sales Volume-Based Market Share by Material Condition (2021-2032)
Figure 40. Global Nitinol Thrombectomy Stent Revenue-Based Market Share by Material Condition (2021-2032)
Figure 41. Global Nitinol Thrombectomy Stent ASP by Material Condition (US$/Unit), 2021-2032
Figure 42. Global Nitinol Thrombectomy Stent Sales Market Share by Application (2021-2032)
Figure 43. Global Nitinol Thrombectomy Stent Revenue-Based Market Share by Application (2021-2032)
Figure 44. Global Nitinol Thrombectomy Stent ASP by Application (US$/Unit), 2021-2032
Figure 45. North America Nitinol Thrombectomy Stent Sales YoY (K Units), 2021-2032
Figure 46. North America Nitinol Thrombectomy Stent Revenue YoY (US$ Million), 2021-2032
Figure 47. North America Top 5 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2025
Figure 48. North America Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2021-2032)
Figure 49. North America Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 50. US Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 51. Canada Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 52. Mexico Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 53. Europe Nitinol Thrombectomy Stent Sales YoY (K Units), 2021-2032
Figure 54. Europe Nitinol Thrombectomy Stent Revenue YoY (US$ Million), 2021-2032
Figure 55. Europe Top 5 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2025
Figure 56. Europe Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2021-2032)
Figure 57. Europe Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 58. Germany Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 59. France Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 60. U.K. Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 61. Italy Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 62. Russia Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 63. Asia-Pacific Nitinol Thrombectomy Stent Sales YoY (K Units), 2021-2032
Figure 64. Asia-Pacific Nitinol Thrombectomy Stent Revenue YoY (US$ Million), 2021-2032
Figure 65. Asia-Pacific Top 8 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2025
Figure 66. Asia-Pacific Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2021-2032)
Figure 67. Asia-Pacific Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. Indonesia Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 69. Japan Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 70. South Korea Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 71. China Taiwan Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 72. India Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 73. Central and South America Nitinol Thrombectomy Stent Sales YoY (K Units), 2021-2032
Figure 74. Central and South America Nitinol Thrombectomy Stent Revenue YoY (US$ Million), 2021-2032
Figure 75. Central and South America Top 5 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2025
Figure 76. Central and South America Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2021-2032)
Figure 77. Central and South America Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 78. Brazil Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 79. Argentina Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 80. Middle East, and Africa Nitinol Thrombectomy Stent Sales YoY (K Units), 2021-2032
Figure 81. Middle East and Africa Nitinol Thrombectomy Stent Revenue YoY (US$ Million), 2021-2032
Figure 82. Middle East and Africa Top 5 Manufacturers Nitinol Thrombectomy Stent Sales Revenue (US$ Million) in 2025
Figure 83. Middle East and Africa Nitinol Thrombectomy Stent Sales Volume (K Units) by Application (2021-2032)
Figure 84. Middle East and Africa Nitinol Thrombectomy Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 85. GCC Countries Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 86. Turkey Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 87. Egypt Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 88. South Africa Nitinol Thrombectomy Stent Revenue (US$ Million), 2021-2032
Figure 89. Nitinol Thrombectomy Stent Industry Chain Mapping
Figure 90. Regional Nitinol Thrombectomy Stent Manufacturing Base Distribution (%)
Figure 91. Global Nitinol Thrombectomy Stent Production Market Share by Region (2021-2032)
Figure 92. Nitinol Thrombectomy Stent Production Process
Figure 93. Regional Nitinol Thrombectomy Stent Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Nitinol Thrombectomy Stent in 2032?
The global market size of Nitinol Thrombectomy Stent in 2032 was 411 Million USD.
What is the annual compound growth rate of the global Nitinol Thrombectomy Stent market size from 2026 to 2032?
Which region is expected to have the highest market share?
What was the global market size of Nitinol Thrombectomy Stent in 2026?
Which companies rank high in the global Nitinol Thrombectomy Stent market?
Related Reports
Global Nitinol Thrombectomy Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nitinol Thrombectomy Stent market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 411 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 97
USD 4250.00
(Single User License)
Nitinol Thrombectomy Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 411 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 121
USD 3950.00
(Single User License)
Global Nitinol Thrombectomy Stent Market Research Report 2026
The global Nitinol Thrombectomy Stent market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 411 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 127
USD 2900.00
(Single User License)
Global Nitinol Thrombectomy Stent Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nitinol Thrombectomy Stent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 175
USD 4900.00
(Single User License)
Global Nitinol Thrombectomy Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nitinol Thrombectomy Stent market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 108
USD 4250.00
(Single User License)
Nitinol Thrombectomy Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 137
USD 3950.00
(Single User License)
Global Nitinol Thrombectomy Stent Market Research Report 2025
The global market for Nitinol Thrombectomy Stent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 100
USD 2900.00
(Single User License)
Global and United States Nitinol Thrombectomy Stent Market Report & Forecast 2024-2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 146
USD 4350.00
(Single User License)
Global Nitinol Thrombectomy Stent Market Insights, Forecast to 2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 182
USD 4900.00
(Single User License)
Nitinol Thrombectomy Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 140
USD 3950.00
(Single User License)
Global Nitinol Thrombectomy Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Nitinol Thrombectomy Stent market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 411 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 97
USD 4250.00 (Single User License)Nitinol Thrombectomy Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 411 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-03-15
Pages: 121
USD 3950.00 (Single User License)Global Nitinol Thrombectomy Stent Market Research Report 2026
The global Nitinol Thrombectomy Stent market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 411 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-03-15
Pages: 127
USD 2900.00 (Single User License)Global Nitinol Thrombectomy Stent Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Nitinol Thrombectomy Stent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 175
USD 4900.00 (Single User License)Global Nitinol Thrombectomy Stent Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Nitinol Thrombectomy Stent market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 108
USD 4250.00 (Single User License)Nitinol Thrombectomy Stent - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 137
USD 3950.00 (Single User License)Global Nitinol Thrombectomy Stent Market Research Report 2025
The global market for Nitinol Thrombectomy Stent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 100
USD 2900.00 (Single User License)Global and United States Nitinol Thrombectomy Stent Market Report & Forecast 2024-2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 146
USD 4350.00 (Single User License)Global Nitinol Thrombectomy Stent Market Insights, Forecast to 2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 182
USD 4900.00 (Single User License)Nitinol Thrombectomy Stent- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 140
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now